St. Jude Children's Research Hospital: Neuroblastoma trials

The registry lists 24 Neuroblastoma studies with St. Jude Children's Research Hospital as lead sponsor. 4 are open to participants now and 3 have results posted.

Early Phase 1 1Phase 1 12Phase 2 8No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing SarcomaRecruitingNCT04901702Phase 1/2
• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)RecruitingNCT04897321Phase 1
• Familial Investigations of Childhood Cancer PredispositionRecruitingNCT03050268
• Molecular Analysis Of Solid TumorsRecruitingNCT01050296
• Therapy for Children With Advanced Stage NeuroblastomaCompletedNCT01857934Phase 2Results posted
• A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) in High Risk Abdominal NeuroblastomaTerminatedNCT01440283Phase 2Results posted
• Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk NeuroblastomaTerminatedNCT00808899Phase 2Results posted
• Indocyanine Green (ICG) Guided Tumor ResectionCompletedNCT04084067Phase 1
• 18F-Fluorodopamine PET Studies of Neuroblastoma and PheochromocytomaActive, not recruitingNCT03541720Early Phase 1
• SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsCompletedNCT03434262Phase 1
• Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A AntibodyCompletedNCT02159443
• A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or LymphomasCompletedNCT02130869Phase 1
• A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and LymphomasCompletedNCT01625351Phase 1
• Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory NeuroblastomaCompletedNCT01576692Phase 1
• Methionine PET/CT Studies In Patients With CancerActive, not recruitingNCT00840047Phase 2
• A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and MelanomaCompletedNCT00743496Phase 1
• Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked ProductsCompletedNCT00695279
• Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide ChemotherapyCompletedNCT00187109Phase 1/2
• Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory NeuroblastomaCompletedNCT00186862Phase 1
• Therapy for Children With Advanced Stage High Risk NeuroblastomaCompletedNCT00186849Phase 2
• Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and LymphomasCompletedNCT00152126Not applicable
• Therapy for Children With NeuroblastomaCompletedNCT00135135Phase 2
• ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid TumorsCompletedNCT00132158Phase 1
• Gene Therapy in Treating Children With Refractory or Recurrent NeuroblastomaCompletedNCT00002748Phase 1